Spondyloarthritis & psoriatic arthritis

Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial

RMD OpenPublished Secondary analysis of the SIAS cohort and ASSERT randomised trial

Authors' conclusion

In r-axSpA, vertebral corner inflammation may lead to syndesmophyte formation but in a minority of cases via visible fat deposition.

Study context

Population
Patients with radiographic axial spondyloarthritis (r-axSpA), assessed at T0, T1 (SIAS: 1 year; ASSERT: 24 weeks) and T2 (2 years)vertebral corners with baseline fat or syndesmophyte ignored
Participants
49 vs 168
Comparison
Vertebral corner inflammation at T0 vs no inflammation, with new fat deposition as mediator
  • SIASn = 49
  • ASSERTn = 168
Primary endpoint
Proportion of the total effect of vertebral corner inflammation on new syndesmophyte formation explained via intermediate new fat deposition
Follow-up
T2 (2 years)
Methodological detailsmediation analysis, vertebral corner level analysis
  • Mediation analysis
  • Vertebral corner level analysis

Primary result

As reported in the abstract

Effect of inflammation (T0) on new syndesmophyte in same vertebral corner (T2): total effect and part via new fat deposition (mediation analysis)
SIAS: total effect of inflammation on probability of new syndesmophyte
9.3%
SIAS: effect via intermediate new fat deposition
0.2%
SIAS: proportion of total effect via new fat deposition
2%
ASSERT: total effect
7.3%
ASSERT: effect via new fat deposition
0.8%
ASSERT: proportion of total effect via new fat deposition
10%

Original publication

Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial. RMD Open. Published 5 July 2023. doi:10.1136/rmdopen-2023-003118

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.